These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9354417)

  • 1. Antiarrhythmic therapy--future trends and forecast for the 21st century.
    Böcker D; Block M; Hindricks G; Borggrefe M; Breithardt G
    Am J Cardiol; 1997 Oct; 80(8A):99G-104G. PubMed ID: 9354417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
    Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P
    Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J; Abdelhadi R
    Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a future for antiarrhythmic drug therapy?
    Guerra PG; Talajic M; Roy D; Dubuc M; Thibault B; Nattel S
    Drugs; 1998 Nov; 56(5):767-81. PubMed ID: 9829152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What remains of anti-arrhythmia drugs?].
    Lévy S
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1501-5. PubMed ID: 8010849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in implantable cardioverter defibrillators.
    Swygman C; Wang PJ; Link MS; Homoud MK; Estes NA
    Curr Opin Cardiol; 2002 Jan; 17(1):24-8. PubMed ID: 11790930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on arrhythmias and cardiac pacing 2013.
    Almendral J; Pombo M; Martínez-Alday J; González-Rebollo JM; Rodríguez-Font E; Martínez-Ferrer J; Castellanos E; García-Fernández FJ; Ruiz-Mateas F
    Rev Esp Cardiol (Engl Ed); 2014 Apr; 67(4):294-304. PubMed ID: 24774592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative arrhythmias and the role for implantable cardioverter-defibrillators.
    Campbell RW
    Curr Opin Cardiol; 1993 Nov; 8(6):932-7. PubMed ID: 10146522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of ventricular arrhythmias: state of the art.
    Stevenson WG
    Heart Rhythm; 2013 Dec; 10(12):1919-26. PubMed ID: 24120875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling cardiac arrhythmias: an overview with a historical perspective.
    Singh BN
    Am J Cardiol; 1997 Oct; 80(8A):4G-15G. PubMed ID: 9354407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P; Newman D; Greene M
    Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on management of cardiac arrhythmias in acute coronary syndromes.
    Willich T; Goette A
    Minerva Cardioangiol; 2015 Apr; 63(2):121-33. PubMed ID: 25612305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The progress of electrical treatment of arrhythmia].
    Fang ZX
    Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Jan; 26(1):3-6. PubMed ID: 16104147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.